Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Ortho-McNeil scientists discover new androgen receptor modulators

Dec. 5, 2003

Protein prenyltransferase inhibitors newly identified at PPD Discovery

Dec. 5, 2003

In vivo efficacy of drugs targeting tumor vasculature

Dec. 4, 2003

Telcyta awarded fast track status for third-line therapy of NSCLC

Dec. 4, 2003

Xcytrin granted fast track status for brain metastases in NSCLC patients

Dec. 4, 2003

Maxim licenses MX-90745 series to Myriad

Dec. 4, 2003

Rolling NDA submission continues for Onco TCS

Dec. 4, 2003

German approval for Leuprogel one-month depot product

Dec. 4, 2003

New inhibitors of ERK2 and other protein kinases covered by Vertex patent

Dec. 4, 2003

AxyS and Cytovia patent novel caspase activators for use as antitumor agents

Dec. 4, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...